An Unblinded, Comparative, Randomized Study of Influenza A/H1N1 2009 Resistance in Patients With Standard and Double Dose Oseltamivir Treatment.

Trial Profile

An Unblinded, Comparative, Randomized Study of Influenza A/H1N1 2009 Resistance in Patients With Standard and Double Dose Oseltamivir Treatment.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Oct 2016

At a glance

  • Drugs Oseltamivir (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 08 Jul 2011 Additional lead trial center (National Centre for Immunisation Research and Surveillance) added as reported by Australian New Zealand Clinical Trials Registry.
    • 08 Jul 2011 New source added and integrated (Australian New Zealand Clinical Trials Registry, ACTRN12610000004066).
    • 18 Jan 2011 Actual end date (Dec 2010 ) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top